Patents by Inventor Eileen Remold-O'Donnell

Eileen Remold-O'Donnell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR TREATING AUTOIMMUNE DISEASE
    Publication number: 20210163609
    Abstract: Described herein are methods and compositions for treating an autoimmune disease. Aspects of the methods described herein relate, in part, to administering to a subject an agent that targets CXCR6. Another aspect of the methods described herein relate, in part, to administering to a subject an agent that inhibits SerpinB1.
    Type: Application
    Filed: April 9, 2019
    Publication date: June 3, 2021
    Applicant: THE CHILDREN'S MEDICAL CENTER CORPORATION
    Inventors: Eileen REMOLD-O'DONNELL, Lifei HOU
  • Human monocyte elastase inhibitor antibodies
    Patent number: 5827672
    Abstract: A new human elastase inhibitor is provided. The human monocyte elastase inhibitor is isolated, purified, characterized at the molecular level and cloned. The human monocyte elastase inhibitor is capable of forming a covalent complex with elastase or Proteinase-3 and is capable of inhibiting elastase.
    Type: Grant
    Filed: June 13, 1996
    Date of Patent: October 27, 1998
    Assignee: Center for Blood Research, Inc.
    Inventor: Eileen Remold-O'Donnell
  • Human monocyte elastase inhibitor
    Patent number: 5663299
    Abstract: A new human elastase inhibitor is provided. The human monocyte elastase inhibitor is isolated, purified, characterized at the molecular level and cloned. The human monocyte elastase inhibitor is capable of forming a covalent complex with elastase or Proteinase-3 and is capable of inhibiting elastase.
    Type: Grant
    Filed: September 30, 1994
    Date of Patent: September 2, 1997
    Assignee: Center for Blood Research, Inc.
    Inventor: Eileen Remold-O'Donnell
  • Cloned gene encoding human monocyte elastase inhibitor
    Patent number: 5370991
    Abstract: A cloned gene encoding a new human elastase inhibitor is provided. The cloned gene is isolated, purified, and sequenced. The cloned gene encoding a human elastase inhibitor that is substantially non-glycosylated, is capable of forming a covalent complex with elastase and is capable of inhibiting elastase.
    Type: Grant
    Filed: September 6, 1991
    Date of Patent: December 6, 1994
    Assignee: The Center for Blood Research, Inc.
    Inventor: Eileen Remold-O'Donnell